Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: RT who wrote (13463)	8/17/1998 10:19:00 AM
From: John W. Andrews	Respond to of 23519

Approval in Canada was granted....

To: RT who wrote (13463)	8/17/1998 10:20:00 AM
From: betty moyers	Read Replies (1) \| Respond to of 23519

I L O V E love it but what is it?

To: RT who wrote (13463)	8/17/1998 10:30:00 AM
From: VLAD	Read Replies (1) \| Respond to of 23519

RT, I believe that the meetings with institutional investors last week has resulted in institutional accumulation of Vivus stock. Vivus was probably giving the institutions a lot of the positive information regarding MUSE earnings potential in foreign markets. It is a big mistake to think that sales of MUSE in the US in the presence of Viagra will correlate to sales in other countries. Don't forget that millions of Viagra tablets have already been sold on black markets so in essence for those who really wanted it, Viagra already has a significant head start on MUSE. Again, we must keep a close eye on what happens with MUSE sales in countries such as Switzerland and England. Don't forget about the big A card Vivus still holds.